GlassScriptPhysician profile
Philip E Fidler
NPI 1689643637
$3,173.46
in general payments reported to CMS, 2019-2025
10 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $62.41 · 2021: $172 · 2022: $720 · 2023: $1,342 · 2024: $460 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040 · Charitable Contribution: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.21 |
| Charitable Contribution | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $1,245.31 | 2019-2023 | Recell |
| Integra Lifesciences Corporation | $633.89 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $573.26 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ovik Health, LLC | $258.33 | 2019-2025 | Assist Silver |
| Medline Industries LP | $191.11 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.14 | 2022 | |
| Smith+Nephew, INC. | $78.18 | 2025 | Versajet |
| Vertex Pharmaceuticals Incorporated | $28.42 | 2025 | |
| Polynovo North America LLC | $22.55 | 2025 | Novosorb Btm |
| Urgo Medical North America, LLC | $18.27 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Fidler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.